Emerging Strategies to Optimize Therapeutic Benefit in Advanced Gastrointestinal and Lung Cancers

Gain expert perspectives on new approaches for gastrointestinal and lung cancers through an on-demand Webcast with downloadable slides plus a focused commentary.

Mary Jo Fidler, MD

John L. Marshall, MD

On-Demand Webcast

Multimedia

Emerging Strategies to Optimize Therapeutic Benefit in Gastrointestinal and Lung Cancers

View Multimedia

Clinical experts discuss key data in GI and lung malignancies from ASCO 2020 and the optimization of therapeutic benefit through management of cancer cachexia syndrome.

Mary Jo Fidler, MD

John L. Marshall, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: August 28, 2020 Expired: No longer available for credit

Emerging Strategies to Optimize Therapeutic Benefit in Gastrointestinal and Lung Cancers: GI Updates (19 mins)

Emerging Strategies to Optimize Therapeutic Benefit in GI and Lung Cancers: Lung Updates (23 mins)

Cancer Cachexia Syndrome and Patient Cases (25 mins)